Angiodynamics (ANGO) Other Non-Current Liabilities (2012 - 2026)

Angiodynamics (ANGO) has 15 years of Other Non-Current Liabilities data on file, last reported at $16.3 million in Q2 2026.

• Quarterly Other Non-Current Liabilities fell 3.54% year-over-year to $16.3 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $16.3 million (down 3.54% YoY) and the FY2026 annual result came in at $16.3 million, down 3.54% from the prior year.
• Other Non-Current Liabilities eased to $16.3 million in Q2 2026, from $16.7 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $17.4 million in Q1 2025 to a low of $2.6 million in Q4 2023.
• A 5-year average of $11.5 million and a median of $14.2 million in 2025 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2023 — Other Non-Current Liabilities sank 81.58% — and 2024, when it jumped 355.53%.
• Tracing ANGO's Other Non-Current Liabilities over 5 years: stood at $9.1 million in 2022, then plunged by 71.32% to $2.6 million in 2023, then jumped by 355.53% to $11.9 million in 2024, then surged by 43.88% to $17.1 million in 2025, then decreased by 4.39% to $16.3 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $16.3 million (Q2 2026), $16.7 million (Q1 2026), and $17.1 million (Q4 2025), per Business Quant data.